Loading...

Home
ETF
ENLV

ENLV

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ENLV News

Enlivex Therapeutics' RAIN Token Listed on KuCoin, Expected to Enhance Liquidity

Jan 14 2026Benzinga

Enlivex Adopts First RAIN Prediction Market Token Strategy, Secures $212 Million Funding

Nov 26 2025Globenewswire

Three Penny Stocks to Keep an Eye On as of November 25, 2025

Nov 25 2025TipRanks

Dow Rises by 300 Points; Waldencast Stock Takes a Dive

Nov 24 2025Benzinga

Enlivex Secures $212 Million PIPE and Appoints Former Italian PM Matteo Renzi to Board

Nov 24 2025Newsfilter

D. Boral Capital Lowers Enlivex Therapeutics Rating to Hold

Nov 24 2025Benzinga

Nasdaq Rises by 350 Points; Enlivex Therapeutics Stock Jumps Significantly

Nov 24 2025Benzinga

Enlivex Launches RAIN Prediction Markets Token Strategy with $212 Million PIPE Financing

Nov 24 2025Newsfilter

EXCLUSIVE: Enlivex Secures More Than $200 Million to Initiate First Public Company Prediction Markets Venture

Nov 24 2025Benzinga

Enlivex Reports Six-Month Efficacy Data for Allocetra™ in Knee Osteoarthritis

Nov 24 2025Newsfilter

Enlivex Appoints former Italy Prime Minister Matteo Renzi to Board of Directors

Nov 24 2025PRnewswire

Enlivex Therapeutics Plans to Secure $212M Through PIPE for Prediction-Markets Token Fund

Nov 24 2025SeekingAlpha

Enlivex Shares Rise Following Positive 6-Month Outcomes in Knee Osteoarthritis Study

Nov 24 2025SeekingAlpha

Biotech Stocks Fluctuate Post-Market: Delcath Gains from Buyback, BioVie and Cassava Recover

Nov 21 2025NASDAQ.COM

Enlivex Therapeutics to Showcase 3-Month Phase IIa Data on Allocetra for Moderate-to-Severe Knee Osteoarthritis at ACR Convergence 2025

Oct 28 2025Newsfilter

D. Boral Capital to Present KOL Webinar Showcasing Insights and Innovations from Enlivex's Knee Osteoarthritis Program with Top Global Experts

Sep 29 2025Newsfilter